Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Dec;34(12):3056–3062. doi: 10.1128/jcm.34.12.3056-3062.1996

Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA.

Z Wang 1, B G Hansson 1, O Forslund 1, L Dillner 1, M Sapp 1, J T Schiller 1, B Bjerre 1, J Dillner 1
PMCID: PMC229459  PMID: 8940448

Abstract

To investigate whether cervical mucus antibodies against human papillomavirus (HPV) capsids are associated with the detection of HPV DNA or HPV-related cytological diagnoses, 611 samples of cervical secretions from 359 women referred to a colposcopy clinic were tested by an enzyme-linked immunosorbent assay for the presence of immunoglobulin A (IgA) antibodies against HPV capsids of HPV type 16, 18, or 33 and for the presence of cervical HPV DNA by PCR. Among subjects with at least one cervical sample positive for HPV type 16 (HPV-16) DNA, 28.1% also had at least one HPV-16 IgA-positive cervical sample (odds ratio [OR] = 2.9; P = 0.0003). IgA to HPV-18 was also more common among HPV-18 DNA-positive subjects (OR = 3.1; P = 0.0325) and IgA to HPV-33 was more common among HPV-33 DNA-positive subjects (OR = 4.2; P = 0.0023). Cervical IgA antibodies to HPV-16 were also more common among patients with cervical intraepithelial neoplasia, particularly among patients with cervical intraepithelial neoplasia grade I (P < 0.0005). The data indicate that an HPV type-restricted IgA antibody response against HPV capsids is detectable in cervical mucus and is associated with a concomitant cervical HPV infection.

Full Text

The Full Text of this article is available as a PDF (195.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson-Ellström A., Dillner J., Hagmar B., Schiller J., Sapp M., Forssman L., Milsom I. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Transm Dis. 1996 May-Jun;23(3):234–238. doi: 10.1097/00007435-199605000-00013. [DOI] [PubMed] [Google Scholar]
  2. Bistoletti P., Zellbi A., Moreno-Lopez J., Hjerpe A. Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN) III. Cancer. 1988 Nov 1;62(9):2056–2059. doi: 10.1002/1097-0142(19881101)62:9<2056::aid-cncr2820620931>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  3. Breitburd F., Kirnbauer R., Hubbert N. L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J. T., Lowy D. R. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol. 1995 Jun;69(6):3959–3963. doi: 10.1128/jvi.69.6.3959-3963.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cheng G., Icenogle J. P., Kirnbauer R., Hubbert N. L., St Louis M. E., Han C., Svare E. I., Kjaer S. K., Lowy D. R., Schiller J. T. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis. 1995 Dec;172(6):1584–1587. doi: 10.1093/infdis/172.6.1584. [DOI] [PubMed] [Google Scholar]
  5. Christensen N. D., Kreider J. W., Shah K. V., Rando R. F. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. J Gen Virol. 1992 May;73(Pt 5):1261–1267. doi: 10.1099/0022-1317-73-5-1261. [DOI] [PubMed] [Google Scholar]
  6. Dillner J., Kallings I., Brihmer C., Sikström B., Koskela P., Lehtinen M., Schiller J. T., Sapp M., Mårdh P. A. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis. 1996 Jun;173(6):1394–1398. doi: 10.1093/infdis/173.6.1394. [DOI] [PubMed] [Google Scholar]
  7. Dillner L., Bekassy Z., Jonsson N., Moreno-Lopez J., Blomberg J. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int J Cancer. 1989 Jan 15;43(1):36–40. doi: 10.1002/ijc.2910430109. [DOI] [PubMed] [Google Scholar]
  8. Dillner L., Fredriksson A., Persson E., Forslund O., Hansson B. G., Dillner J. Antibodies against papillomavirus antigens in cervical secretions from condyloma patients. J Clin Microbiol. 1993 Feb;31(2):192–197. doi: 10.1128/jcm.31.2.192-197.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elfgren K., Bistoletti P., Dillner L., Walboomers J. M., Meijer C. J., Dillner J. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am J Obstet Gynecol. 1996 Mar;174(3):937–942. doi: 10.1016/s0002-9378(96)70330-7. [DOI] [PubMed] [Google Scholar]
  10. Forslund O., Hansson B. G., Rymark P., Bjerre B. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol. 1993 Aug;31(8):1975–1979. doi: 10.1128/jcm.31.8.1975-1979.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Guerrero E., Daniel R. W., Bosch F. X., Castellsagué X., Muñoz N., Gili M., Viladiu P., Navarro C., Zubiri M. L., Ascunce N. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol. 1992 Nov;30(11):2951–2959. doi: 10.1128/jcm.30.11.2951-2959.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hansson B. G., Forslund O., Bjerre B., Lindholm K., Nordenfelt E. Human papilloma virus types in routine cytological screening and at colposcopic examinations. Eur J Obstet Gynecol Reprod Biol. 1993 Nov;52(1):49–55. doi: 10.1016/0028-2243(93)90225-2. [DOI] [PubMed] [Google Scholar]
  13. Heino P., Eklund C., Fredriksson-Shanazarian V., Goldman S., Schiller J. T., Dillner J. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst. 1995 Mar 15;87(6):437–440. doi: 10.1093/jnci/87.6.437. [DOI] [PubMed] [Google Scholar]
  14. Kirnbauer R., Hubbert N. L., Wheeler C. M., Becker T. M., Lowy D. R., Schiller J. T. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst. 1994 Apr 6;86(7):494–499. doi: 10.1093/jnci/86.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lorincz A. T., Reid R., Jenson A. B., Greenberg M. D., Lancaster W., Kurman R. J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992 Mar;79(3):328–337. doi: 10.1097/00006250-199203000-00002. [DOI] [PubMed] [Google Scholar]
  16. Rymark P., Forslund O., Hansson B. G., Lindholm K. Genital HPV infection not a local but a regional infection: experience from a female teenage group. Genitourin Med. 1993 Feb;69(1):18–22. doi: 10.1136/sti.69.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wideroff L., Schiffman M. H., Nonnenmacher B., Hubbert N., Kirnbauer R., Greer C. E., Lowy D., Lorincz A. T., Manos M. M., Glass A. G. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis. 1995 Dec;172(6):1425–1430. doi: 10.1093/infdis/172.6.1425. [DOI] [PubMed] [Google Scholar]
  18. Wikström A., van Doornum G. J., Quint W. G., Schiller J. T., Dillner J. Identification of human papillomavirus seroconversions. J Gen Virol. 1995 Mar;76(Pt 3):529–539. doi: 10.1099/0022-1317-76-3-529. [DOI] [PubMed] [Google Scholar]
  19. zur Hausen H. Viruses in human cancers. Science. 1991 Nov 22;254(5035):1167–1173. doi: 10.1126/science.1659743. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES